US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist

6.170
+0.060+0.98%

Close Dec 13 16:00 ET

6.170
0.0000.00%

Post 19:59 ET

393.69MMarket Cap-5.37P/E (TTM)

Larimar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Larimar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Larimar Therapeutics Earnings Reports

Larimar Therapeutics | 10-Q: Q3 2024 Earnings Report

Oct 30 17:07 ET

Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results

Oct 30 07:07 ET

Larimar Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 14:44 ET

Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Second Quarter 2024 Operating and Financial Results

Aug 7 07:06 ET

Analyst Rating

Updated: Dec 14, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall